Nikkei Biotech has published an interview with our CEO Dai Takehara, and our Director/Head of R&D Dr. Park.
Special Feature: Peptide Drug Discovery Finally Taking Off
“The Future of PPI Drug Discovery: A Conversation with PRISM BioLab CEO Dai Takehara”
https://bio.nikkeibp.co.jp/atcl/news/p1/25/04/15/13203/